Zine-Eddine Khene
@zineeddinekhene
Research Fellow @UTSWUrology 🇺🇸 /MD urologist at @CHURennes 🇫🇷 & PhD st @LTSI Data Scientist | Machine Learning | Radiomics | Genito Urinary Cancer
ID: 708945489845227520
https://urologie-rennes.fr/accueil/ 13-03-2016 09:19:11
880 Tweet
457 Followers
573 Following
Best candidate for TMT is the same for surgery. We have to consider results from TMT according to the candidate. “Maybe we remove too many bladders?”Karim Bensalah
Super proud and moved to see so many young talents from CHU de Rennes Service d'urologie Rennes on the program of the annual congress of the French urologists in training AFUF #papaestfierdevous Claire Richard Goujon Anna Mehdi EL AKRI
Le miracle des numéros spéciaux des revues scientifiques, conséquence de la médiocrité de certains milieux académiques, fait le bonheur de marchands de rêves predatoryreports.org/news/f/the-mir… via Predatory Journals
DFS is important in the adjuvant setting and it is great to finally see OS benefit in #KN564 after adjuvant #RCC treatment, BUT: ➡️With OS not being the primary EP, informative #censoring + unequal subsequent #treatment may impact results 👉ascopubs.org/doi/full/10.12… Tomer Meirson
Thrilled to report our latest paper "Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review" in the European Urology Oncology Solène-Florence Kammerer-Jacquet @VitalyMargulis Morgan Roupret Karim Bensalah CHU de Rennes UT Southwestern Urology euoncology.europeanurology.com/article/S2588-…
Excellent article on #Digital and Computational #Pathology in #KidneyCancer #RCC #AI: ➡️Not perfect yet for clinical routine, but yielding great future potential ➡️Key aspects: detection, classification (grade, subtypes), outcome predictions 👉 euoncology.europeanurology.com/article/S2588-…
🤔 #JCO #CommentsAndControversies: It's time to bid farewell to PFS as a primary endpoint in practice-changing trials in advanced cancer ➡️ brnw.ch/21wEmpU Elizabeth Eisenhauer Bishal Gyawali, MD, PhD, FASCO Ian Tannock
Online now: Penile fractures: the price of a merry Christmas Nikolaos (Nikos) Pyrgidis geraldschulz Michael Chaloupka Paulo L. Pfitzinger Maria Apfelbeck Julian Marcon bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
🚨 New format coming your way! 🚨 We’re excited to introduce the YAU Renal Cancer Spotlight on Minerva Urology and Nephrology ! YAU members will #explore #hot #topics in renal cancer, providing expert insights in an #editorial #format. 🧬 Stay up-to-date with the latest research and
From the August Issue of Annals of Surgical Oncology : Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration #kidneydisease Paolo Dell'Oglio Carlo Andrea Bravi Zine-Eddine Khene Riccardo Campi rdcu.be/dRnkC
1⃣. online meeting 👇 ⏺️EAU Endourology - AI & Technology WG 👨💻🧠🤖 Olivier Traxer European Association of Urology (EAU) ⚡️ Let's start ! Carlotta Nedbal Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 Pieter De Backer Chady Ghnatios Zine-Eddine Khene Peter Kronenberg Tzevat TEFIK Ben Turney @fpanthier
RESEARCH REPORT: BCG therapy for bladder cancer: Exploring patient experiences and concerns through artificial intelligence-based social media analysis by Zine-Eddine KHENE et al. journals.sagepub.com/doi/10.1177/23… Dr. Bishoy M. Faltas Dan Theodorescu splernerMD
Sequential gemcitabine and docetaxel examined in BCG-unresponsive #BladderCancer patients. yair lotan UT Southwestern Urology joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss a multicenter retrospective study comparing sequential intravesical gemcitabine and docetaxel (gem/doce) with BCG in
Surgical outcomes of radical nephrectomy and inferior vena cava thrombectomy following preoperative systemic immunotherapy: a propensity score analysis. #AuthorCommentary on UroToday > bit.ly/3Yazt6U Zine-Eddine Khene Raj Bhanvadia Wadih Issa, MD Solomon Woldu Kris Gaston, MD, FACS Hans Hammers
Sequential gemcitabine and docetaxel examined in BCG-unresponsive #BladderCancer patients. yair lotan UT Southwestern Urology joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center to discuss a multicenter retrospective study comparing sequential intravesical gemcitabine and docetaxel (gem/doce) with BCG in
ARTICLE INSIGHTS! Thank you Bogdana Schmidt MD, MPH for your insights into "Gemcitabine vs Bacillus Calmette-Guérin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer." Click for more #TheVoiceOfUrology #AUA bit.ly/4jIUe1J